Searched for
MRNA BASED VACCINES
To win the deep-tech race, India needs ‘General Innovation Rules’India is launching ambitious science initiatives. However, current financial rules designed for conventional procurement hinder R&D. A new ...- Moderna stocks: MRNA shares jump in US Stock market today after pharma giant surpasses Wall Street estimatesModerna had earlier posted a loss of $2.52 per share a year earlier, while analysts expected a loss of $3.96 per share.
- Emcure and its subsidiary Gennova settle legal dispute with HDT Bio over mRNA technologyEmcure Pharmaceuticals and its subsidiary Gennova have resolved all legal disputes with US-based HDT Bio Corp. The parties have entered int...
- Emcure Pharma gets relief in $950-million lawsuitThe US district judge James Robart upheld the Indian drug maker's argument that the court lacked jurisdiction over the company and dismisse...
- Sanofi says it's back to the drawing board on mRNA flu vaccinesSanofi, one of the top global vaccine makers, has stated that the current mRNA technology used in COVID-19 vaccines is not effective agains...
- DCGI grants Emergency Use Authorization to Gennova biopharma's Omicron-specific covid boosterThe mRNA-based vaccine was developed by Gennova Biopharmaceuticals using the indigenous platform technology, and supported under the Missio...
- Cancer vaccines are being developed using tech similar to that used for Covid shotsDecades before Covid vaccines, scientists had been working on messenger ribonucleic acid (mRNA) vaccines targeting cancer.
- China okays its first mRNA vaccine, from drugmaker CSPCChina, whose home-grown vaccines are seen as less effective than the Moderna and Pfizer-BioNTech mRNA shots, has been racing to develop vac...
- COVID-19 mRNA vaccines increase risk of cardiac-related death, says Florida Surgeon GeneralThe Florida Department of Health (Department) conducted an analysis through a self-controlled case series, which is a technique originally ...
- Panel recommends emergency use nod to India's 1st mRNA vaccineThe Subject Expert Committee recommended the authorisation in a meeting held on Friday. The vaccine is developed by Pune-based Gennova Biop...
- DCGI approves indigenous mRNA Covid jab for emergency use in 18 yrs & aboveAbout 70 lakh doses of the vaccine have already been cleared by the government’s nodal Central Drug Laboratory (CDL) at Kasauli and it is e...
- Gennova closes in on nod for mRNA vax developed in IndiaGennova had in April submitted interim data on India's first indigenously developed mRNA Covid-19 vaccine to the Central Drug Standard Cont...
- Biological E to get mRNA technology from WHO to make COVID-19VaccinesWHO along with its partners will work with the Indian government and BE to develop a roadmap and put in place the necessary training and su...
- Gennova Biopharmaceuticals developing Omicron specific vaccineGennova Biopharmaceuticals, a subsidiary of Pune-based drugmaker Emcure Pharmaceuticals, is developing a Covid-19 vaccine on its mRNA platf...
- Gennova to finish Phase 2 & 3 trials of its mRNA jab by January 2022The company had submitted the interim Phase-1 clinical trial data to CDSCO, where it tested for safety and immunogenicity.
- No sign of Pfizer, Moderna Covid vaccines in breast milk: StudyThe study, published in the journal JAMA Pediatrics, offers the first direct data of vaccine safety during breastfeeding and could allay co...
- A cure for cancer: After Covid vaccine, next mRNA miracle might be closer than you imagineThe new technology was not only lightning fast but also incredibly effective - mRNA Covid vaccines from both Moderna and Pfizer hit the bul...
- HGCO19 vaccine candidate: Gennova starts enrolment for Phase 1/2 human clinical trialsThe DBT said it has approved additional funding towards clinical studies of India's first of its kind' mRNA-based COVID-19 vaccine, HGCO19,...
- Pfizer, Moderna vaccines may greatly reduce risk of asymptomatic COVID-19 infection, study saysThe Pfizer-BioNTech and Moderna messenger RNA (mRNA) vaccines for COVID-19 are authorised for emergency use in many countries. An mRNA vacc...
- Gennova Biopharma to start mRNA vaccine trials by the year's end; results likely in March '21The trial results are likely to come in by March 2021, Sanjay Singh, CEO of Pune-based Gennova, told ET. There is a possibility that India ...
Load More
